Concepedia

Yongxin Han

YH

Statistics

Publications

70

Citations

4.3K

H-Index

36

Active since

1993

Affiliations

Merck Canada Inc. (Canada)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Quantitative BioSciences

University of Minnesota

China-Japan Friendship Hospital

Yongxin Han is an author at Merck Canada Inc. (Canada) specializing in medicinal chemistry, pharmacology, and drug discovery.

ORCID

Publications per year

1993–2024

70

Publications

70

Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte

Richard S. Hotchkiss, K. Chang, Paul E. Swanson et al. · Nature Immunology · 2000 · 527 citations

, , +14

Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis

Sofi G. Julien, Nadia Dubé, Michelle Read et al. · Nature Genetics · 2007 · 320 citations

, , +16

<i>gem-</i>Difluoroolefination of Diazo Compounds with TMSCF<sub>3</sub> or TMSCF<sub>2</sub>Br: Transition-Metal-Free Cross-Coupling of Two Carbene Precursors

Mingyou Hu, Chuanfa Ni, Lingchun Li et al. · Journal of the American Chemical Society · 2015 · 279 citations · Full text

, , +10

Occurrence and Minimization of Cysteine Racemization during Stepwise Solid-Phase Peptide Synthesis<sup>1</sup><sup>,</sup><sup>2</sup>

Yongxin Han, Fernando Alberício, George Bárány · The Journal of Organic Chemistry · 1997 · 214 citations

, , +7

Selective, Reversible Caspase-3 Inhibitor Is Neuroprotective and Reveals Distinct Pathways of Cell Death after Neonatal Hypoxic-ischemic Brain Injury

Byung Hee Han, Daigen Xu, Junjeong Choi et al. · Journal of Biological Chemistry · 2002 · 177 citations · Full text

, , +17

1–5 of 70